• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Atricure Inc (NQ: ATRC )

    33.52 +0.02 (+0.04%)
    Streaming Delayed Price Updated: 2:04 PM EST, Nov 4, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Atricure Inc

    < Previous 1 2 3 Next >
    Snap Posts Upbeat Earnings, Joins Unisys, AtriCure, Garmin And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Navigating 6 Analyst Ratings For AtriCure
    Via Benzinga
    Analyst Ratings For AtriCure
    Via Benzinga
    Cracking The Code: Understanding Analyst Reviews For AtriCure
    Via Benzinga
    Key Takeaways From AtriCure Analyst Ratings
    Via Benzinga
    Cracking The Code: Understanding Analyst Reviews For AtriCure
    Via Benzinga
    ATRC Stock Earnings: AtriCure Meets EPS, Beats Revenue for Q2 2024
    ATRC stock results show that AtriCure met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
    Via InvestorPlace
    Have 20 Bucks? 7 Low-Priced Stocks That Could Double by 2025
    Low priced stocks to buy for growth provide great value to investors in the $20 range and are expected to pop before 2025. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    ATRC Stock Earnings: AtriCure Misses EPS, Beats Revenue for Q1 2024
    ATRC stock results show that AtriCure missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Coinbase To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Friday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Recap: AtriCure Q4 Earnings
    Via Benzinga
    Earnings Scheduled For February 15, 2024
    Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
    Via Benzinga
    AtriCure's Earnings: A Preview
    Via Benzinga
    Key Takeaways From AtriCure Analyst Ratings
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Where AtriCure Stands With Analysts
    Via Benzinga
    New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market
    Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies’ (NASDAQ: BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in Ne 
    Via Benzinga
    What 7 Analyst Ratings Have To Say About AtriCure
    Via Benzinga
    Analyst Ratings for AtriCure
    Via Benzinga
    Earnings Outlook For AtriCure
    Via Benzinga
    5 Analysts Have This to Say About AtriCure
    Within the last quarter, AtriCure (NASDAQ:ATRC) has observed the following analyst ratings: 
    Via Benzinga
    Moderna To Rally Over 42%? Here Are 10 Other Price Target Changes For Monday
    Morgan Stanley cut VTEX (NYSE: VTEX) price target from $7 to $5.  Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. VTEX shares fell 4.9% to close at $3.52 on... 
    Via Benzinga
    AtriCure: Q2 Earnings Insights
    AtriCure (NASDAQ:ATRC) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by... 
    Via Benzinga
    5 Analysts Have This to Say About AtriCure
    Over the past 3 months, 5 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
    Via Benzinga
    Analyst Ratings for AtriCure
    Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
    Via Benzinga
    AtriCure's Q1 EPS Miss Estimates, Needham Lowers Price Target
    Needham lowered AtriCure Inc's (NASDAQ: ATRC) price target to $67 from $79 due to peer multiple compression, with the Buy rating unchanged. 
    Via Benzinga
    4 Analysts Have This to Say About AtriCure
    Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
    Via Benzinga
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.